Cost-Effectiveness of Posaconazole Compared with Standard Azole Therapy for Prevention of Invasive Fungal Infections in Patients at High Risk in Switzerland

By  

Oncology, Vol. 78, Iss. 3-4, 2010-04 ,pp. : 172-180

Karger

Access to resources Recommend Favorite

Use of posaconazole delayed‐release tablets for treatment of invasive aspergillosis

By  

MYCOSES (ELECTRONIC), Vol. 58, Iss. 5, 2015-05 ,pp. : 313-314

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cost-effectiveness of primary antifungal prophylaxis with posaconazole versus itraconazole in allogeneic hematopoietic stem cell transplantation

By Sánchez-Ortega Isabel  

Journal of Medical Economics, Vol. 16, Iss. 6, 2013-06 ,pp. : 736-743

Informa Healthcare

Access to resources Recommend Favorite

Assessment of survival in a 2-year comparative study of lanthanum carbonate versus standard therapy

By Wilson R.   Zhang P.   Smyth M.   Pratt R.  

Current Medical Research and Opinion, Vol. 25, Iss. 12, 2009-12 ,pp. : 3021-3028

Informa Healthcare

Access to resources Recommend Favorite

Intravenous Itraconazole followed by Oral Itraconazole for the Treatment of Amphotericin-B-Refractory Invasive Pulmonary Aspergillosis

By  

Acta Haematologica, Vol. 109, Iss. 3, 2003-05 ,pp. : 111-118

Karger

Access to resources Recommend Favorite